Alignment Healthcare
ALHC · Health Care Services
$8.06
4.4%Hims & Hers Health
HIMS · Health Care Services
$27.71
4.9%The short version
- Alignment Healthcare is the larger business, with $3.9B of revenue in fiscal 2025 against $2.3B for Hims & Hers Health, about 1.7 times as much.
- Hims & Hers Health grew revenue faster (59.0%, against 46.1%).
- Hims & Hers Health kept more of each dollar of sales as operating profit (4.5% operating margin, against 0.4% operating margin).
| Latest fiscal year | ALHC · FY25 | HIMS · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.7B | $6.4B |
| Revenue | $3.9B | $2.3B |
| Free cash flow | $113M | $57.4M |
| Net income | −$0.7M | $128M |
| Growth | ||
| Revenue growth | 46.1% | 59.0% |
| 5-year growth | 32.7% | 73.6% |
| Share count change | 3.8% | 9.1% |
| Profitability | ||
| Gross margin | — | 73.8% |
| Operating margin | 0.4% | 4.5% |
| Net margin | −0.0% | 5.5% |
| FCF margin | 2.9% | 2.5% |
| Return on capital | — | 19.0% |
| Return on equity | −0.5% | 25.2% |
| Balance sheet | ||
| Net debt | −$281M | $395M |
| Net debt / EBITDA | −6.2x | 2.5x |
| Dividends and buybacks | $0.0M | $90.0M |
| Valuation & quality | ||
| P/E | 42.4x | — |
| Piotroski F-score | 5 | 4 |
FY19
ALHC $757M
HIMS $82.6M
FY20
ALHC $959M
HIMS $149M
FY21
ALHC $1.2B
HIMS $272M
FY22
ALHC $1.4B
HIMS $527M
FY23
ALHC $1.8B
HIMS $872M
FY24
ALHC $2.7B
HIMS $1.5B
FY25
ALHC $3.9B
HIMS $2.3B
ALHC
HIMS
FY19
ALHC −3.9%
HIMS −90.1%
FY20
ALHC −0.6%
HIMS −10.2%
FY21
ALHC −15.3%
HIMS −42.3%
FY22
ALHC −9.0%
HIMS −13.0%
FY23
ALHC −7.0%
HIMS −3.4%
FY24
ALHC −3.8%
HIMS 4.2%
FY25
ALHC 0.4%
HIMS 4.5%
ALHC
HIMS
FY19
ALHC —
HIMS −$75.2M
FY20
ALHC —
HIMS −$4.2M
FY21
ALHC —
HIMS −$35.2M
FY22
ALHC −$69.2M
HIMS −$33.7M
FY23
ALHC −$95.2M
HIMS $47.0M
FY24
ALHC −$6.7M
HIMS $198M
FY25
ALHC $113M
HIMS $57.4M
ALHC
HIMS
FY19
ALHC —
HIMS —
FY20
ALHC —
HIMS —
FY21
ALHC —
HIMS —
FY22
ALHC —
HIMS −49.5%
FY23
ALHC —
HIMS −18.2%
FY24
ALHC —
HIMS 41.3%
FY25
ALHC —
HIMS 19.0%
ALHC
HIMS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.